Healthcare provider profile · identity verified

Drew Ernest Polson, MD

Family Practice · SPANISH FORK, UT · NPI 1700084829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	520	160
Levothyroxine Sodium	Levothyroxine Sodium	362	111
Lisinopril	Lisinopril	247	75
Amlodipine Besylate	Amlodipine Besylate	239	76
Losartan Potassium	Losartan Potassium	236	74
Rosuvastatin Calcium	Rosuvastatin Calcium	228	77
Pantoprazole Sodium	Pantoprazole Sodium	192	67
Hydrochlorothiazide	Hydrochlorothiazide	143	43
Metoprolol Succinate	Metoprolol Succinate	140	45
Metformin Hcl Er	Metformin Hcl	137	40
Montelukast Sodium	Montelukast Sodium	133	52
Omeprazole	Omeprazole	126	37
Tamsulosin Hcl	Tamsulosin Hcl	125	44
Glipizide Er	Glipizide	122	36
Sertraline Hcl	Sertraline Hcl	119	35
Trazodone Hcl	Trazodone Hcl	112	34
Gabapentin	Gabapentin	101	41
Pravastatin Sodium	Pravastatin Sodium	101	29
Albuterol Sulfate Hfa	Albuterol Sulfate	99	29
Metformin Hcl	Metformin Hcl	93	32
Meloxicam	Meloxicam	91	38
Mounjaro	Tirzepatide	90	13
Tizanidine Hcl	Tizanidine Hcl	88	20
Ozempic	Semaglutide	87	23
Duloxetine Hcl	Duloxetine Hcl	85	22
Naproxen	Naproxen	79	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	22
Carvedilol	Carvedilol	65	23
Simvastatin	Simvastatin	65	20
Tramadol Hcl	Tramadol Hcl	63	25
Citalopram Hbr	Citalopram Hydrobromide	57	18
Clonazepam	Clonazepam	57	11
Clopidogrel	Clopidogrel Bisulfate	57	18
Furosemide	Furosemide	55	22
Pioglitazone Hcl	Pioglitazone Hcl	55	19
Zolpidem Tartrate	Zolpidem Tartrate	54	16
Allopurinol	Allopurinol	53	17
Fluticasone Propionate	Fluticasone Propionate	51	14
Eszopiclone	Eszopiclone	50	11
Ibuprofen	Ibuprofen	50	12
Alprazolam	Alprazolam	48	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	19
Ondansetron Odt	Ondansetron	47	suppressed
Pregabalin	Pregabalin	47	22
Quetiapine Fumarate	Quetiapine Fumarate	47	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Synthroid	Levothyroxine Sodium	45	15
Prednisone	Prednisone	43	29
Escitalopram Oxalate	Escitalopram Oxalate	41	15
Fenofibrate	Fenofibrate	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	13
Jardiance	Empagliflozin	40	12
Propranolol Hcl	Propranolol Hcl	40	13
Celecoxib	Celecoxib	39	11
Alendronate Sodium	Alendronate Sodium	38	15
Bupropion Xl	Bupropion Hcl	37	13
Azelastine Hcl	Azelastine Hcl	36	18
Famotidine	Famotidine	36	12
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Cholestyramine	Cholestyramine (With Sugar)	33	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Finasteride	Finasteride	31	14
Valacyclovir	Valacyclovir Hcl	31	14
Atenolol	Atenolol	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Eliquis	Apixaban	29	suppressed
Fluconazole	Fluconazole	29	11
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Rizatriptan	Rizatriptan Benzoate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Spironolactone	Spironolactone	26	11
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Terbinafine Hcl	Terbinafine Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Azithromycin	Azithromycin	21	18
Buspirone Hcl	Buspirone Hcl	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	21	suppressed
Estradiol	Estradiol	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Armour Thyroid	Thyroid,pork	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Piroxicam	Piroxicam	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	11
Mirabegron Er	Mirabegron	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Acyclovir	Acyclovir	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Linzess	Linaclotide	16	suppressed
Valsartan	Valsartan	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Epinephrine	Epinephrine	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nystatin	Nystatin	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Olopatadine Hcl	Olopatadine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error